Resources about HMOs and their potential contributions to infant health and development.
Resources about HMOs and their potential contributions to infant health and development.
The addition of HMOs to infant formulas represents the most significant recent innovation in infant nutrition. Watch a video summarizing the multifunctional benefits of prevalent HMOs on infant health.
Watch videos covering the infant’s developing immune system and the relationships among their immune health, gut, and nutrition.
This infographic highlights the preclinical research that suggests providing HMOs across all 3 categories may work in complementary ways to provide potential benefits for infants.
Dr Hackam and Dr Buck discuss how HMOs function in the body and the possible role they play in the infant’s developing immune system.
Dr John Thomas Stutts, MPH, talks about 5 of the most abundant HMOs in human breast milk and the role of HMOs in supporting digestive health, immune system health, and brain development in infants.
Watch Dr John Thomas Stutts, MPH, share clinical findings on the benefits of HMOs and how they impact digestive health, the developing immune system, and their possible role in brain development for infants.
In this course, identify research on how 2′-FL HMO helps narrow differences between formula and breast milk; review clinical studies supporting HMOs in immune support; and discuss why 2′-FL HMO may be relevant for the dietary management of infants with food allergy.
In this on-demand CME webinar, Lars Bode, PhD, and David J Hackam, MD, PhD, FACS, discuss the latest knowledge on the importance of HMOs on the gut-brain axis, neurocognitive development, and immune health; illustrate practical methods for incorporating recent findings that support the use of HMOs in infant nutrition strategies.
In this on-demand CME webinar, Lars Bode, PhD, and David J. Hackam, MD, PhD, FACS, explore the diversity of human milk oligosaccharides and their impact on gut dysbiosis and other parameters of infant health, including immune function and cognitive development.
This article discusses the need for a healthy microbiome and how it is essential for appropriate development of the body’s immune responses. Human milk oligosaccharides, including 2′-fucosyllactose, promote the development of a healthy microbiome by promoting proliferation of beneficial bacteria and suppressing growth of pathogenic organisms.
In this 11-minute podcast, Elena Oliveros, PhD, summarizes the results of a study she and her team published in Journal of Food Science, titled “Human Milk Levels of 2'-Fucosyllactose and 6'-Sialyllactose are Positively Associated with Infant Neurodevelopment and are Not Impacted by Maternal BMI or Diabetic Status.”
This infographic outlines how HMOs are unique prebiotics found naturally in human milk and offer particular benefits for a developing infant.
This infographic explains how 2'-fucosyllactose (2'-FL) human milk oligosaccharide (HMO) is the most abundant HMO, found in 75-85% of mothers' breast milk. HMO has system-wide effects in the gut, immune system and brain. It also explains the important outcomes and benefits of 2'-FL HMO discovered through clinical and preclinical research.
This article describes how recent evidence reveals HMOs' abundance in breast milk and their various beneficial effects toward infants' health.
This course reviews the emerging role of the human milk oligosaccharide, 2'-fucosyllactose (2'-FL), in allergy modulation and discusses 2'-FL potential mechanisms of action. It also recognizes the importance of breastfeeding. Originally presented on June 6, 2019 at the ESPGHAN Conference in Glasgow, Scotland.
The course reviews clinical studies supporting the immune benefits of 2'-fucosyllactose human milk oligosaccharide (2'-FL HMO); discusses preclinical evidence of 2'-FL HMO effects on food allergy and potential mechanisms of action; and describes the possible role of 2'-FL HMO in enhancing oral tolerance. Originally presented as a live webinar on June 3, 2020.
In this course, learn about the history, source, and biology of human milk oligosaccharides. This program was originally presented at the Nutrition & Growth Conference in Paris, France on March 1, 2018.
This course reviews human milk oligosaccharides (HMOs); summarizes potential direct and indirect HMO effects; discusses maternal genetic and environmental factors that influence HMO composition; and evaluates the current state of evidence for the role of HMOs in diseases. Originally presented at the HMO Summit on March 4, 2019 in Granada, Spain.
Your sample eligibility has been revoked. You are no longer eligible to send samples to patients.
Would you like to submit this sample eligibility approval request to ?
Click “Yes” to confirm.
You are about to decline 's sample eligibility request.
Would you like to approve ’s sample eligibility request? This will be the only eligible user that you can approve to send samples while they are linked to your account.
Click “Yes” to confirm.
Would you like to revoke ’s sample eligibility?
Click “Yes” to confirm.
Would you like to submit this request to revoke your sample eligibility?
Click “Yes” to confirm.
Request has been declined.
Please be aware that the website you have requested to view is intended for Healthcare Professionals and may not be owned or maintained by Abbott. A new window will open in your browser once you select “yes”. You can return to this site by clicking the back arrow.
Do you wish to continue and exit this website?